Cardiovascular health in children and young adults with chronic conditions
Official title: Cardiovascular Risk in Children With Chronic Conditions Study
Run by Semmelweis University · NCT07086989 · Data updated 2026-11-12
This project will see if children and young adults (ages 6-25) with chronic health conditions show early signs of aging in large and small blood vessels using noninvasive imaging and clinical tests.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 6 Years to 25 Years |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Semmelweis University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 3 sites (Budapest and 2 other locations) |
| Status | Recruiting |
| Started | April 1, 2025 |
| Main results expected | January 31, 2029 |
| Study ends | January 31, 2029 |
| Registry record updated | August 8, 2025 |
| Trial ID | NCT07086989 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children and young adults aged 6-25 with chronic childhood conditions linked to higher early cardiovascular risk (for example type 1 or type 2 diabetes, chronic kidney disease, kidney transplant history, or familial hypercholesterolaemia) are ideal candidates.
✕Probably not a fit
Patients with severe intellectual or developmental disability, decompensated heart failure, severe primary immunodeficiency, ongoing intravenous chemotherapy, active infectious diseases posing public-health risk, or those outside the 6-25 age range are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study will enroll participants aged 6-25 who have chronic childhood conditions linked to higher cardiovascular risk. Investigators will use noninvasive measures such as carotid artery imaging and retinal vessel imaging alongside clinical measures of inflammation and metabolic status to characterize vascular aging. The study will consider disease-related factors (for example diabetes or chronic kidney disease), treatment-related effects (such as long-term steroids or chemotherapy), and lifestyle-related contributors. The goal is to identify early vascular markers and underlying mechanisms that could guide future monitoring and prevention strategies.
Why it matters
Potential benefit: If successful, the findings could identify early vascular changes and markers that help clinicians target monitoring and preventive care to reduce future heart and blood vessel disease.
How similar studies have gone: Previous observational studies have detected early carotid and retinal vascular changes in some chronic conditions, but interventions targeting these mechanisms are still largely untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: 1. Individuals aged between 6 and 25 years; 2. Diagnosed with a chronic childhood condition/disease associated with an increased risk of early cardiovascular disease; 3. Provided informed consent (if over 18 years old) or had informed consent provided by their legal guardian (if under 18 years old) following appropriate information about the study. Chronic childhood conditions/diseases associated with increased risk of early cardiovascular disease are defined according to the 2019 American Heart Association recommendations (https://doi.org/10.1161/CIR.0000000000000618), as well as other conditions/diseases for which at least two large-scale epidemiological studies have demonstrated an increased risk of cardiovascular disease. Exclusion criteria: 1. Severe intellectual and developmental disability; 2. Decompensated heart failure; 3. Severe primary immunodeficiency; 4. Ongoing intravenous chemotherapy; 5. Infectious diseases posing a public health risk; or 6. History of regular alcohol or drug use.
Where it's running
-
Semmelweis University, Pediatric Center
Budapest, Hungary Recruiting -
Semmelweis University, Department of Surgery, Transplantation and Gastroenterology
Budapest, Hungary Not yet recruiting -
Semmelweis University, Institute of Preventive Medicine and Public Health
Budapest, Hungary Active not recruiting
Study contacts
- Principal investigator: Tamas Kiss, MD, PhD — Semmelweis University, Pediatric Center
- Study coordinator: Tamas Kiss, MD, PhD
- Email: kiss.tamas1@semmelweis.hu
- Phone: +36202478885
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Improving outcomes for stem cell transplant patients using an intervention website
This study is testing if a special website can help adults with blood cancer feel better and improve their quality of life after a stem cell transplant compared to a regular educational website.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
Expanding HIV-positive donor livers for HIV-positive recipients
This study tests whether liver transplants from HIV-positive donors to HIV-positive recipients are safe regarding opportunistic infections and cancer.
-
Arterial stiffness in children and young people with CKD and hypertension
This study will test whether arterial stiffness is higher in children and young people with chronic kidney disease and high blood pressure compared with their peers, using a one-time assessment and follow-up for those with high BP.
-
Genetics of Blood Cancers in the U.S. population
This study tests how genetic factors relate to blood cancers by collecting saliva DNA and online health surveys from at least 10,000 U.S. adults.
-
Lifestyle program to help blood pressure and kidney health in adults with advanced CKD
A 12-week lifestyle program with diet, supervised exercise, and coaching is being tested to see if it lowers blood pressure and helps kidney health in adults with advanced chronic kidney disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.